Role of renin-angiotensin system and oxidative stress on vascular inflammation in insulin resistence model

International Journal of Hypertension

Volumn 2013, Issue , 2013, Pages

  Renna, N F ^a   Lembo, C ^b   Diez, E ^b   Miatello, R M ^a  

^a UNIVERSIDAD NACIONAL DE CUYO   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CANDESARTAN; CHOLESTEROL; CYTOKINE; DRINKING WATER; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FRUCTOSE; GAMMA INTERFERON; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEPTIN; MACROPHAGE INFLAMMATORY PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 1; NERVE GROWTH FACTOR BETA SUBUNIT; PROTEIN CINC2; PROTEIN CINC3; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TEMPOL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCOSE TOLERANCE TEST; HEART WEIGHT; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; MALE; MESENTERIC ARTERY; METABOLIC SYNDROME X; MORPHOMETRICS; NONHUMAN; OXIDATIVE STRESS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; TISSUE HOMOGENATE; VASCULAR TISSUE; VASCULITIS;

EID: 84873396911     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.1155/2013/420979     Document Type: Article

References (23)

1. Ross R., Atherosclerosis-an inflammatory disease. The New England Journal of Medicine 1999 340 2 115 126 10.1056/NEJM199901143400207 (Pubitemid 29054847)
2. Tedgui A., Mallat Z., Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiological Reviews 2006 86 2 515 581 2-s2.0-33645891172 10.1152/physrev.00024.2005
3. Paukku K., Silvennoinen O., STATs as critical mediators of signal transduction and transcription: lessons learned from STAT5. Cytokine and Growth Factor Reviews 2004 15 6 435 455 2-s2.0-9244243110 10.1016/j.cytogfr.2004.09.001 (Pubitemid 39550454)
4. Hansson G. K., Libby P., The immune response in atherosclerosis: a double-edged sword. Nature Reviews Immunology 2006 6 7 508 519 2-s2.0-33745571976 10.1038/nri1882 (Pubitemid 43980523)
5. Brand K., Page S., Walli A. K., Neumeier D., Baeuerle P. A., Role of nuclear factor- B in atherogenesis. Experimental Physiology 1997 82 2 297 304 2-s2.0-0030889302
6. Ross R., The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993 362 6423 801 809 2-s2.0-0027241856 10.1038/362801a0 (Pubitemid 23132154)
7. Raines E. W., Ferri N., Cytokines affecting endothelial and smooth muscle cells in vascular disease. Journal of Lipid Research 2005 46 6 1081 1092 2-s2.0-24944452395 10.1194/jlr.R500004-JLR200 (Pubitemid 43109823)
8. Singer C. A., Salinthone S., Baker K. J., Gerthoffer W. T., Synthesis of immune modulators by smooth muscles. BioEssays 2004 26 6 646 655 2-s2.0-2942590336 10.1002/bies.20041 (Pubitemid 38758342)
9. Von der Thüsen J. H., Kuiper J., Van Berkel T. J. C., Biessen E. A. L., Interleukins in atherosclerosis: molecular pathways and therapeutic potential. Pharmacological Reviews 2003 55 1 133 166 2-s2.0-0037370316 10.1124/pr.55.1.5 (Pubitemid 36268401)
10. Tedgui A., Mallat Z., Anti-inflammatory mechanisms in the vascular wall. Circulation Research 2001 88 9 877 887 2-s2.0-0035843995 (Pubitemid 32441465)
11. Carretero O. A., Oparil S., Essential hypertension. Part I: definition and etiology. Circulation 2000 101 3 329 335 2-s2.0-0034711753 (Pubitemid 30054162)
12. Keaney J. F., Gaziano J. M., Xu A., Frei B., Curran-Celentano J., Shwaery G. T., Loscalzo J., Vita J. A., Dietary antioxidants preserve endothelium-dependent vessel relaxation in cholesterol-fed rabbits. Proceedings of the National Academy of Sciences of the United States of America 1993 90 24 11880 11884 2-s2.0-0027146693 10.1073/pnas.90.24.11880 (Pubitemid 24008743)
13. Furchgott R. F., Zawadzki J. V., The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980 288 5789 373 376 2-s2.0-0019195506 (Pubitemid 11169009)
14. Ignarro L. J., Byrns R. E., Buga G. M., Wood K. S., Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circulation Research 1987 61 6 866 879 2-s2.0-0023518452 (Pubitemid 18004583)
15. Fleming I., Busse R., Signal transduction of eNOS activation. Cardiovascular Research 1999 43 3 532 541 2-s2.0-0033566864 10.1016/S0008- 6363(99)00094-2 (Pubitemid 29369252)
16. Michel J. B., Feron O., Sase K., Prabhakar P., Michel T., Caveolin versus calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase. Journal of Biological Chemistry 1997 272 41 25907 25912 2-s2.0-0030770629 10.1074/jbc.272.41.25907 (Pubitemid 27438916)
17. Renna N., Vazquez M. A., Lama M. C., González E. S., Miatello R. M., Effect of chronic aspirin administration on an experimental model of metabolic syndrome. Clinical and Experimental Pharmacology and Physiology 2009 36 2 162 168 10.1111/j.1440-1681.2008.05042.x
18. Risler N., Castro C., Cruzado M., González S., Miatello R., Early changes in proteoglycans production by resistance arteries smooth muscle cells of hypertensive rats. American Journal of Hypertension 2002 15 5 416 421 2-s2.0-0036256879 10.1016/S0895-7061(02)02263-X (Pubitemid 34478481)
19. Cruzado M. C., Risler N. R., Miatello R. M., Yao G., Schiffrin E. L., Touyz R. M., Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: effect of angiotensin II and role of insulinlike growth factor-1 receptor transactivation. American Journal of Hypertension 2005 18 1 81 87 2-s2.0-13244290055 10.1016/j.amjhyper.2004.09.001 (Pubitemid 40187353)
20. Siegel D., Swislocki A. L. M., Effects of antihypertensives on glucose metabolism. Metabolic Syndrome and Related Disorders 2007 5 3 211 219 2-s2.0-34548610921 10.1089/met.2007.0016 (Pubitemid 47402027)
21. Renna, Lembo C N., Diez E., Miatello R., Garcia C. M. L., Gonzalez P. A. P., Vascular repair by endothelial progenitor cells ina an experimental model of metabolic syndrome. Handbook on Metabolic Syndrome: Classification, Risk Factors and Health Impact 2012 New York, NY, USA Nova Science
22. Renna N. F., Diez E., Lembo C., Miatello R. M., Role of COX-2 in vascular inflammation, an experimental model of metabolic syndrome. Mediators of Inflammation. In press 10.1155/2012/513251
23. Schiffrin E. L., Touyz R. M., From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension. American Journal of Physiology 2004 287 2 H435 H446 2-s2.0-3242718855 10.1152/ajpheart.00262.2004 (Pubitemid 38960790)